Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued ADHD symptom control and tolerability after abrupt conversion

OBJECTIVE: To evaluate symptom control and tolerability after abrupt conversion from oral extended-release methylphenidate (ER-MPH) to methylphenidate transdermal system (MTS) via a dose-transition schedule in children with attention-deficit/hyperactivity disorder (ADHD). METHODS: In a 4-week, prosp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Arnold, L. E., Hodgkins, P., McKay, M., Beckett-Thurman, L., Greenbaum, M., Bukstein, O., Patel, A., Bozzolo, D. R.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3875401/
https://ncbi.nlm.nih.gov/pubmed/19916704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1185/03007990903437412
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars